Form C - Offering Statement:
SEC Accession No. 0001665160-24-001662
Filing Date
2024-11-19
Accepted
2024-11-19 15:16:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9674
2 offeringmemoformc.pdf EX-99 19677807
  Complete submission text file 0001665160-24-001662.txt   27110318
Mailing Address 615 DAVIS DR. SUITE 800 SUITE 800 MORRISVILLE NC 27560
Business Address 615 DAVIS DR. SUITE 800 MORRISVILLE NC 27560 919-765-6696
Vast Therapeutics, Inc. (Filer) CIK: 0002041605 (see all company filings)

EIN.: 821250808 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-35163 | Film No.: 241475622